Lipid-lowering response in subjects with the p.(Leu167del) mutation in the APOE gene

This publication has 22 references indexed in Scilit:

• APOE p.Leu167del mutation in familial hypercholesterolemia
  Atherosclerosis, 2013
• Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: Consensus Statement of the European Atherosclerosis Society
  European Heart Journal, 2013
• Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study
  The Lancet, 2013
• Apolipoprotein E gene mutations in subjects with mixed hyperlipidemia and a clinical diagnosis of familial combined hyperlipidemia
  Atherosclerosis, 2012
• Molecular characterization of familial hypercholesterolemia in Spain
  Atherosclerosis, 2012
• Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia
  New England Journal of Medicine, 2008
• Statins as effectors of key activities involved in apoE-dependent VLDL metabolism: Review and hypothesis
  Vascular Pharmacology, 2008
• Genetic causes of familial hypercholesterolaemia in patients in the UK: relation to plasma lipid levels and coronary heart disease risk
  Journal of Medical Genetics, 2006
• Guidelines for the diagnosis and management of heterozygous familial hypercholesterolemia
  Atherosclerosis, 2004
• Effect of apolipoprotein E and A-IV phenotypes on the low density lipoprotein response to HMG CoA reductase inhibitor therapy
  Atherosclerosis, 1995